Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types

Download this short summary slideset of key takeaways from a live CCO Webinar on the use of biomarkers to identify patients who may benefit from immune checkpoint therapy across various solid tumors.

Jamie E. Chaft, MD John L. Marshall, MD Scot Niglio, MD Released: July 15, 2020

Download this slideset from John L. Marshall, MD to review key data on the use of MSI/MMR testing and immunotherapy for patients with GI cancers.

John L. Marshall, MD Released: July 9, 2020

Download this slideset from Scot Niglio, MD to see an overview of how IO biomarkers are currently used for patients with GU cancers, with key data on immunotherapy approaches for bladder cancer, RCC, and prostate cancer.

Scot Niglio, MD Released: July 9, 2020

Download this slideset from Jamie E. Chaft, MD to see a summary of key data on the use of immune checkpoint inhibitor therapy for patients with lung cancer, with information on when IO biomarkers are needed to select optimal therapy.

Jamie E. Chaft, MD Released: July 9, 2020